Highland Capital Management, LLC Amgen Inc Transaction History

Highland Capital Management, LLC

$1.73 Billion
Q3 2024

A detailed history of Highland Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Highland Capital Management, LLC holds 3,924 shares of AMGN stock, worth $1.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

3,924

Previous 6,402 38.71%

Holding current value

$1.1 Million

Previous $2 Million 36.8%

% of portfolio

0.07%

Previous 0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$309.38 - $337.38 $766,643 - $836,027	-2,478 Reduced 38.71%	3,924 $1.26 Million
Q2 2024 Jul 25, 2024	SELL	$262.75 - $319.31 $319,241 - $387,961	-1,215 Reduced 15.95%	6,402 $2 Million
Q1 2024 May 07, 2024	BUY	$268.87 - $324.56 $2,419 - $2,921	9 Added 0.12%	7,617 $2.17 Million
Q4 2023 Jan 17, 2024	SELL	$255.7 - $288.46 $6,136 - $6,923	-24 Reduced 0.31%	7,608 $2.19 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $30,611 - $38,004	-140 Reduced 1.8%	7,632 $2.05 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $5,785 - $6,840	-27 Reduced 0.35%	7,772 $1.73 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $267,109 - $325,561	-1,183 Reduced 13.17%	7,799 $1.89 Million
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $220,326 - $279,951	962 Added 12.0%	8,982 $2.36 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $23,343 - $26,327	-104 Reduced 1.28%	8,020 $1.81 Million
Q2 2022 Jul 14, 2022	BUY	$230.71 - $256.74 $1,153 - $1,283	5 Added 0.06%	8,124 $1.98 Million
Q1 2022 Apr 19, 2022	BUY	$219.27 - $242.57 $7,016 - $7,762	32 Added 0.4%	8,119 $1.96 Million
Q4 2021 Jan 28, 2022	SELL	$198.88 - $227.6 $19,888 - $22,760	-100 Reduced 1.22%	8,087 $1.82 Million
Q3 2021 Oct 25, 2021	SELL	$212.27 - $248.7 $151,136 - $177,074	-712 Reduced 8.0%	8,187 $1.74 Million
Q2 2021 Jul 30, 2021	SELL	$233.58 - $259.14 $82,687 - $91,735	-354 Reduced 3.83%	8,899 $2.17 Million
Q1 2021 Apr 27, 2021	SELL	$221.91 - $258.6 $158,665 - $184,899	-715 Reduced 7.17%	9,253 $2.3 Million
Q4 2020 Jan 21, 2021	SELL	$216.38 - $257.67 $4.21 Million - $5.02 Million	-19,472 Reduced 66.14%	9,968 $2.29 Million
Q3 2020 Oct 16, 2020	SELL	$234.65 - $260.95 $196,402 - $218,415	-837 Reduced 2.76%	29,440 $7.48 Million
Q2 2020 Jul 22, 2020	BUY	$197.81 - $242.74 $623,299 - $764,873	3,151 Added 11.62%	30,277 $7.14 Million
Q1 2020 May 05, 2020	BUY	$182.24 - $241.7 $1.16 Million - $1.53 Million	6,343 Added 30.52%	27,126 $5.5 Million
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $2.34 Million - $3.01 Million	-12,383 Reduced 37.34%	20,783 $5.01 Million
Q3 2019 Nov 20, 2019	SELL	$174.11 - $208.62 $2.07 Million - $2.47 Million	-11,861 Reduced 26.34%	33,166 $6.42 Million
Q2 2019 Jul 29, 2019	BUY	$166.7 - $195.41 $2.12 Million - $2.49 Million	12,731 Added 39.42%	45,027 $8.3 Million
Q1 2019 Apr 18, 2019	SELL	$180.87 - $203.88 $112,501 - $126,813	-622 Reduced 1.89%	32,296 $6.14 Million
Q4 2018 Jan 16, 2019	SELL	$178.4 - $208.25 $539,660 - $629,956	-3,025 Reduced 8.42%	32,918 $6.41 Million
Q3 2018 Oct 17, 2018	BUY	$185.29 - $208.89 $1.57 Million - $1.77 Million	8,486 Added 30.91%	35,943 $7.45 Million
Q2 2018 Jul 18, 2018	BUY	$166.05 - $186.51 $43,505 - $48,865	262 Added 0.96%	27,457 $5.07 Million
Q1 2018 Apr 16, 2018	BUY	$169.43 - $198.0 $22,195 - $25,938	131 Added 0.48%	27,195 $4.64 Million
Q4 2017 Jan 26, 2018	SELL	$168.79 - $188.59 $83,382 - $93,163	-494 Reduced 1.79%	27,064 $4.71 Million
Q3 2017 Oct 10, 2017	BUY	$167.29 - $191.0 $4.61 Million - $5.26 Million	27,558	27,558 $5.14 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management, LLC with notifications on news.

Account

Highland Capital Management, LLC Amgen Inc Transaction History